NCT06003231 2026-03-16A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2Seagen Inc.Phase 2 Active not recruiting120 enrolled
NCT05980481 2025-09-29A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric CancerRemeGen Co., Ltd.Phase 2/3 Active not recruiting201 enrolled
NCT05586061 2025-02-07RCTSQilu Hospital of Shandong UniversityPhase 2 Active not recruiting55 enrolled